A detailed history of Arrow Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Arrow Financial Corp holds 142 shares of NVS stock, worth $15,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142
Holding current value
$15,699
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$92.57 - $107.37 $13,144 - $15,246
142 New
142 $15,000
Q2 2018

Jul 30, 2018

SELL
$64.91 - $73.36 $45,437 - $51,352
-700 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$74.14 - $77.27 $51,898 - $54,089
700
700 $60,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Arrow Financial Corp Portfolio

Follow Arrow Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.